accountTelegraph.co.uk ISCO reports positive results from pre-clinical in vivo Parkinson's disease study pharmabiz.com International Stem Cell Corporation (ISCO), a California-based biotechnology company, has reported positive 12-week results from its pre-clinical in vivo Parkinson's disease study. The primary goal of this behavioural study was to demonstrate the ... QualityStocks News - International...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to ISCO reports positive results from pre-clinical in vivo Parkinson's disease study - pharmabiz.com
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account